Cargando…

Therapeutic interventions target the NLRP3 inflammasome in ulcerative colitis: Comprehensive study

One of the significant health issues in the world is the prevalence of ulcerative colitis (UC). UC is a chronic disorder that mainly affects the colon, beginning with the rectum, and can progress from asymptomatic mild inflammation to extensive inflammation of the entire colon. Understanding the und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Fares E.M, Ibrahim, Islam M., Ghogar, Osama M, Abd-alhameed, Esraa K., Althagafy, Hanan S., Hassanein, Emad H.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950862/ https://www.ncbi.nlm.nih.gov/pubmed/36844140 http://dx.doi.org/10.3748/wjg.v29.i6.1026

Ejemplares similares

Targeting necroptosis in fibrosis
por: Hassanein, Emad H. M., et al.
Publicado: (2023)

Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation
por: Lv, Qi, et al.
Publicado: (2021)

PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis
por: Han, Liang, et al.
Publicado: (2022)

NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis
por: Itani, Shigehiro, et al.
Publicado: (2016)

Effect of Tripterygium wilfordii Polycoride on the NOXs-ROS-NLRP3 Inflammasome Signaling Pathway in Mice with Ulcerative Colitis
por: Fangxiao, Ma, et al.
Publicado: (2019)

Retracted: PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis
por: Markers, Disease
Publicado: (2023)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis
por: Wagatsuma, Kohei, et al.
Publicado: (2020)

Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome
por: Yu, Tian-Yuan, et al.
Publicado: (2023)

Natural products modulate NLRP3 in ulcerative colitis
por: Xue, Jia-Chen, et al.
Publicado: (2023)

Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome
por: Ruiz, Pedro A, et al.
Publicado: (2017)

COVID-19 and hepatic injury: cellular and molecular mechanisms in diverse liver cells
por: Ali, Fares E M, et al.
Publicado: (2023)

The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
por: Allen, Irving C., et al.
Publicado: (2010)

Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges
por: Ali, Fares E M, et al.
Publicado: (2021)

Oral intake of titanium dioxide nanoparticles affect the course and prognosis of ulcerative colitis in mice: involvement of the ROS-TXNIP-NLRP3 inflammasome pathway
por: Duan, Shumin, et al.
Publicado: (2023)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

Evaluation of anti-ulcer and ulcerative colitis of Sonchus oleraceus L
por: Alothman, Esraa A., et al.
Publicado: (2018)

Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice
por: Zhao, Shengnan, et al.
Publicado: (2016)

GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway
por: Deng, Zhao, et al.
Publicado: (2020)

Caffeic Acid Phenethyl Ester Prevents Colitis-Associated Cancer by Inhibiting NLRP3 Inflammasome
por: Dai, Guoliang, et al.
Publicado: (2020)

C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome
por: Xu, Xueming, et al.
Publicado: (2021)

Microcystin-LR Induces and Aggravates Colitis through NLRP3 Inflammasome-Mediated Pyroptosis in Mice
por: Yang, Yue, et al.
Publicado: (2023)

Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway
por: Liu, Qi, et al.
Publicado: (2020)

Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3
por: Ma, Xingyu, et al.
Publicado: (2022)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA
por: Huang, Jing, et al.
Publicado: (2023)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
por: Arioz, Burak Ibrahim, et al.
Publicado: (2021)

Dicer regulates activation of the NLRP3 inflammasome
por: Ojcius, David M., et al.
Publicado: (2019)

Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly
por: Ding, Wenwen, et al.
Publicado: (2020)

Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating NLRP6 Inflammasomes
por: Li, Yanan, et al.
Publicado: (2022)

Ononin alleviates DSS‐induced colitis through inhibiting NLRP3 inflammasome via triggering mitophagy
por: Yu, Ting, et al.
Publicado: (2023)

Vimentin regulates activation of the NLRP3 inflammasome
por: dos Santos, Gimena, et al.
Publicado: (2015)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

SUMO-mediated regulation of NLRP3 modulates inflammasome activity
por: Barry, Rachael, et al.
Publicado: (2018)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
por: Artlett, Carol M.
Publicado: (2022)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Boron-Based Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_787uj10svbn4kvbl2fpuresao4